Current seminars of the Collaborative Research Centre 900
Current seminars
Our CRC 900 seminar used to take usually place every first Thursday in the month. You find alll our following guest speakers in the archive section. Please also see the list of our regular symposia. Information about the individual research projects can be found on the project pages.
Previous seminars of CRC 900
Previous seminars
03.11.2022
Jennifer Lippincott-Schwartz, PhD, 4D cellular physiology at Howard Hughes Medical Institute, Chavy Chase, Maryland, USA.
„Looking under the hood of cells: from single molecule dynamics to whole cell organelle reconstructions.”
Flyer Jennifer Lippincott-Schwartz
06.10.2022
Prof. Alexander Drakesmith, Professor of Iron Biology, Medical Science Devision, University of Oxford, GB
„Ironing out the immune system.”
01.09.2022
Helen Su, M.D., Ph.D., Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA
„Cytosolic dsRNA sensors and antiviral immunity”
07.07.2022
Prof. Patrick Lomonte, CNRS Research Director, Institut NeuroMyoGène – Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM), Lyon, France
„Epigenetic control of herpesvirus simplex 1 latency. Make room for the S/H/M entity!”
07.07.2022
Prof. Michael Kann, Department of Infectious Diseases, University of Gothenburg, Sweden
„Is host-mediated mutagenesis a general antiviral strategy? Lessons learned from deamination of SARSCoV-2 and influenza viruses in patients.”
05.07.2022
Professor Arash Grakoui, PhD, Division of Infectious Diseases, Department of Medicine and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, USA
„Determinants and mechanisms of protection from HCV infection.”
08.06.2022
Carmen Rivas, PhD, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University Santiago de Compostela, Spain
„Role of SUMOylation in virus replication.”
05.05.2022
Prof. Dr. Tobias Feuchtinger, Department of Pediatric Hematology, Oncology, Stem Cell Transplantation and Hemostaseology, LMU München
„Adoptive Transfer of Virus-Specific T Cells in the Immuncompromised Host”
08.02.2022
Prof. Jan Felix Drexler, Institute of Virology, Charité Berlin
„Epidemiology, evolution and pathogenesis of emerging viruses”
07.02.2022
Prof. Wolfgang Kastenmüller, Würzburg Institute of Systems Immunology, University Würzburg
„How tissue heterogeneity instructs distinct immune responses in draining lymph nodes”
03.02.2022
Prof. Andreas Pichlmair, Institute of Virology, TU München
„Viral nucleic acids: their interactions with cellular proteins and degradation mechanisms”
02.02.2022
Prof. Georg Gasteiger, Würzburg Institute Of Systems Immunology, University Würzburg
„Local players in immunity: Differentiation and Function of Innate Lymphoid Cells”
24.01.2022
Prof. Daniel Pinschewer, Institute of Biomedicine, University of Basel, Switzerland
„Persistent RNA virus infection is short-lived at the single-cell level but leaves transcriptomic footprints”
Dr. Anne Halenius, Institute of Virology, University Hospital Freiburg, Germany
„HLA-class I geno- and allotype specific regulation by human cytomegalovirus encoded glycoproteins.”
04.11.2021
PD Dr. Christoph Welsch, Group „Molecular Evolution & Adaptation“, Goethe University Hospital Frankfurt, Frankfurt/Main
„Role of lipid interactions with hepatitis C virus NS5A protein in membrane remodeling.”
28.10.2021
Prof. Peter O’Hare, Imperial College London, Department of Infectious Disease, UK
„Genome Biology, DNA Sensing and subnuclear platforms during initiation of HSV Infection.”
07.10.2021
Prof. Dr. Sandra Van Puyvelde, University of Antwerp, NL/University of Cambridge, UK
„Adaptation of Salmonella to cause invasive infections in sub-Saharan Africa”
08.09.2021
Prof. Ralph S. Baric, Department of Microbiology and Immunology, UNC Gillings School of Global Public Health, Chapel Hill, USA
„Emerging Coronavirus Pathogenesis and Prevention”
05.08.2021
Prof. Scott Waever, Chair, Department of Microbiology & Immunology, University of Texas Medical Branch, USA
„Mechanisms of Urban Arbovirus Emergence”
01.07.2021
Dr. Alex Price, Weitzmann Lab, Children’s Hospital Philadelphia, USA
„Detection of RNA modifications and novel viral transcripts revealed by direct RNA sequencing.”
03.06.2021
Dr. Boris Bogdanow, Structural Interactomics (AG Fan Liu), Leibniz Forschungsinstitut für molekulare Pharmakologie (FMP), Berlin
„Bridging Perspectives: Structural Interactomics during Herpesvirus Virion and Assembly Stages.”
06.05.2021
Prof. Dr. Dr. Bertram Bengsch, Gastroenterologie, Hepatologie, Endokrinologie und Infektiologie, UK Freiburg
„Exhausted T cells: Metabolic programming in viral hepatitis and role in HCC”
31.03.2021
Nihal Altan-Bonnet Ph.D, Head, Laboratory of Host-Pathogen Dynamics, National Heart Lung and Blood Institute, National Institutes of Health, Washington, USA
“Coronaviral use of lysosomes for egress and its implications for the immune system.”
04.03.2021
Florian I. Schmidt, Ph.D, Institute of Innate Immunity, University Hospitals Bonn, Germany
“Two tales of nanobodies: Dissecting antiviral inflammasomes and SARS-CoV-2 fusion using novel molecular tools.”
PD Dr. Stella Autenrieth, Head of Core Facility Flow Cytometry, Department of Hematology, Oncology, Rheumatology, Immunology, Berg University Hospital Tübingen
“How sleep and infection impacts function and development of myeloid cells.”
05.11.2020
Dr. Alfredo Castello, Departmenr of Biochemistry, University of Oxford, UK
“When viral RNA met the cell: a story of protein-RNA interaction”
01.10.2020 – CANCELLED
01.10.2020 Dr Helen Su, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
01.09.2020
Dr. Emanuel Wyler, Max Delbrück Center of Molecular Medicine, Berlin
“Looking closely at the proper model: single-cell sequencing of coronavirus and herpesvirus infections”
06.08.2020
Prof. Andres Merits, Institute of Technology, University of Tartu, Estonia
“Reconstruction of arbovirus replicase complexes: proteins, RNAs and host factors” (virtual seminar)
14.07.2020
Prof. Felicia Goodrum, Department of Molecular and Cellular Biology, The University of Arizona, Tucson, Arizona, USA
“Making the Switch-Human Cytomegalovirus Latency and Reactivation” (virtual seminar)
04.06.2020 – postponed to 03.09.2020
Dr. Emanuel Wyler, Max Delbrück Center of Molecular Medicine, Berlin
07.05.2020 – postponed to 03.12.2020
PD Dr. Stella Autenrieth, PD Dr. Stella Autenrieth, Head of Core Facility Flow Cytometry, Department of Hematology, Oncology, Rheumatology, Immunology, Berg University Hospital Tübingen
02.04.2020 – CANCELLED
Projectleader of Project B11: Prof. Britta Maecker-Kolhoff, Department of Pediatric Hematology and Oncology, MHH or Prof. Britta Eiz-Vesper, Institute for Transfusion Medicine , MHH.
“Virus-specific T-cell therapy for virus-associated complications before and after transplantation.”
05.03.2020
Dr. Markus Kaymer, Senior Marketing Manager Field Marketing Europe Beckman Coulter Life Sciences and Dr. Michael Kapinsky, Product Manager Flow Cytometry, Beckman Coulter.
“Beckman Coulter – Advancing rigor in clinical research.Call for collaborations.”
06.02.2020
Prof. Günter Höglinger, Clinic of Neurology, Hannover Medical School, Germany
“Pathogen propagation in prion-like disorders.”
Prof. Niklas Arnberg, Units: Section of Virology, Department of Clinical Microbiology, Umea University, Umea, Sweden
“ABC of adenovirus receptors: implications for tropism, treatment, and targeting”
07.11.2019
Dr. Juan Reguera, Groupleader “Viral macromolecular complexes, Architecture et Fonction des Macromolécules Biologiques (AFMB), Marseilles, France
“From negative to positive ssRNA viruses: Different structural solutions to keep the genome readable and protected inside the cell”
27.09.2019
Dr. Janne Bigalke, AstraZeneca, Gothenburg, Sweden
“The great escape: membrane budding mediated by the herpesvirus nuclear egress complex”
18.09.2019
Prof. David M. Knipe, Higgins Professor of Microbiology and Molecular Genetics, Head of Dept. of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, USA
“Virology – Herpes Simplex Virus Infection of Epithelial Cells”
12.09.2019
PD Dr. Martin Winkler, PD Dr. Michael Winkler, Group Leader Infection Biology, German Primate Centre , Leibniz Institute for Primate Research, Göttingen, Germany
“IFITMs and recombinant reporter viruses.”
05.09.2019
Dr. Juan Francisco García Arriaza, Department: Biología Molecular y Celular, Centro Nacional de Biotecnología, Madrid, Spain
“Poxvirus MVA-based vaccines against viral emerging diseases: Ebola and Zika”
01.08.2019
Prof. Thomas Dobner, Head of the Department: Viral Transformation, Heinrich Pette Institut, Hamburg, Germany
“E1B-55k: a multifunctional regulator of virus and cell growth”
27.06.2019
Prof. Arnd Kieser, Helmholtz Zentrum München, German Research Center for Environmental Health, Research Unit Gene Vectors
“The LMP1 oncogene of Epstein-Barr virus – an old dog learns new tricks”
06.06.2019
Prof. Jeremy Wyatt, Wessex Institute, Professor of Digital Healthcare, University of Southampton, UK
“Data quality and causal inference in Learning Health Systems: some challenges for algorithm developers.”
09.05.2019
Dr. Bright Adu, Department of Immunology, Noguchi Medical Research Institute, University of Ghana, Republic of Ghana
“Indicators of naturally acquired immunity to malaria in Ghanaian children.”
04.04.2019
Dr. Pierre Fechter, UMR 7242 „Biotechnology and cell signaling“, CNRS/University of Strasbourg, France
“Iron uptake in Pseudomonas aeruginosa networks different virulence and metabolic pathways”
14.03.2019
Prof. Lisa Fong Poh Ng, Laboratory of Microbial Immunity, Singapore Immunology Network (SIgN), Singapore
“Cellular and molecular mechanisms of arbovirus pathogenesis: from models to therapies”
07.03.2019
Dr. Jan Kisielow, Institute of Molecular Health Sciences, Eidgenössische Technische Hochschule (ETH) Zürich, Swiss
“Deciphering CD4 T-cell specificity for efficient therapeutic interventions”
06.02.2019
Prof. David Wiest, Fox Chase Center, Philadelphia, USA
“A genome-wide approach to understanding gd T cell development and function”
10.01.2019
Prof. Monsef Benkirane, Head of Laboratory of Molecular Virology, Institut de Génétique Humaine, CNS, Montpellier, France
“Crosstalk between DNA Damage response and innate immunity”
05.04.2018
Prof. Benedikt Kaufer, Freie Universität Berlin, Germany
“Herpesvirus Latency: From neuronal modelto Integration into host telomers”
03.05.2018
Dr. Florian Schmidt, University of Bonn, Germany
“Alpaca Nanobodies as Tools to Study the Cell Biology of Infection and Immunity”
08.05.2018
Dr. Franziska Rother, Max-Delbrück Center for Molecular Medicine, University Lübeck, Germany
“Importin alpha7 deficiency causes male infertility by disrupting spermatogenesis”
05.07.2018
Prof. Roosmarijn Vandenbroucke, University of Ghent, Belgium
“The choroid Plexus Epithelium: an important blood-brain barrier that strongly responds to both peripheral and central Inflammation”
Flyer Roosmarijn Vandenbroucke
23.08.2018
Dr. Emanuel Wyler, Max-Delbrück Center for Molecular Medicine, Berlin, Germany
“RNA Systems Virology: Transcriptional and Post-transcriptional Perturbations in Herpes Simplex Virus Infected Cells”
06.09.2018
Prof. Philip Goulder, University of Oxford, UK
“Post-Treatment control vs. elite control in paediatric and adult HIV infection: What do we know?”
04.10.2018
Dr. Dmitriy Chudakov, Institute of Bioorganic Chemistry, Moscow, Russia
“TCR and antibody profiling in health and disease”
04.10.2018
Dr. Moriah Szpara, Pennsylvania State University, USA
“Using clinical cases to explore Herpes Simplex Virus genetic diversity in vivo”
01.11.2018
Dr. Ohad Gal-Mor, Tel-Aviv University, Israel
“Salmonella persistence in humans and the role of the stringent response Regulator DksA in ist pathogenicity”
27.11.2018
Prof. Maija Vihinen-Ranta, University of Jyväskylä, Denmark
“Way out through Chromatin:nuclear egress of herpesvirus”
06.12.2018
Prof. Hinrich Schulenburg, Christian-Albrechts-Universität zu Kiel, Germany
“Evolutionary ecology meets the antibiotic crisis: can we control pathogen adaptation?”
02.02.2017
Dr. David Vermijlen Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium
“Immunity in early life: the case of human gammadelta T cells”
06.04.2017
Prof. Olivier Schwartz Head of Virus und Immunity Unit, Department of Virology, Institut Pasteur, Paris, France
“Viral replication and immune responses: HIV and ZIKA”
04.05.2017
Prof. Urs Greber, Department of Molecular Life Science, University of Zürich, Switzerland
“Virus & Cell Mechanics in Entry & Uncoating”
01.06.2017
Prof. Stacey Efstathiou, Viral Vaccines, The National Institute for Biological Standards and Control (NIBSC), South Mimms, UK
“The ‘Ins and Outs’ of herpes simplex virus latency”
08.06.2017
Prof. Thomas Gramberg, Department of Virology, Universitätsklinikum Erlangen
“The role of SAMHD1 in fending off Retroviruses and endogenous Retroelements”
14.08.2017
Prof. Pierre Guermonprez, Department of Immunobiology, King`s College London, UK
“Monocyte heterogeneity and function”
23.08.2017
Ass. Prof. Jeff Rathmell, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, USA
“Fueling T cells in Inflammation and Tumors”
30.08.2017
Dr. Agnes Wiedemann, INRA, Université Francois-Rabelais, Tours, France
“An updated view on Salmonella invasion mechanisms: still much to discover“
07.09.2017
Dr. Cécile Arrieumerlou, Cochin Institute, Paris, France
“ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria”
05.10.2017
Dr. Cesar Munoz Fontela, HPI Hamburg
“The APC-T cell interface during Ebola virus infection”
01.11.2017
Prof. Luis Picker, OHSU, Oregon, US
“CMV vectors for vaccination against HIV/SIV and M. tuberculosis”
09.11.2017
Dr. Marija-Backovic, Institute Pastuer, France
“Structure-Function Dissection of Pseudorabies Virus Glycoprotein B Fusion Loops”
30.11.2017
Dr. Chris Boutell, University of Glasgow, UK
“Temporal and spatial regulation of host immunity to HSV-1 infection”
07.12.2017
Prof. Jens von Einem, Universitätsklinikum Ulm, Germany
“Regulation of secondary envelopment by herpesvirus tegument”
07.01.2016
Dr. Stéphane Roche Group “Cryo-electron microscopy and X-ray crystallography correlative structural virology”, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France
“A structural characterization of the large tegument protein of Herpes Simplex Virus 1”
04.02.2016
Prof. Jürgen Ruland Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Germany
“C-type Lectin Receptor Signaling in the Innate Immune System”
01.04.2016
Prof. Dr. Tohru Minamino Graduate School of Frontier Biosciences, Osaka University, Japan
“Flagellar type III protein export in Salmonella and the role of chaperones”
04.04.2016
Dr. Lüder Wiebusch Laboratory of Pediatric Molecular Biology, Charité – Universitätsmedizin Berlin, Germany
“Different approaches, one target: cell cycle arrest mechanisms of human and mouse cytomegaloviruses”
12.05.2016
Dr. Noam Stern-Ginossar Department of Molecular Genetics, Weizmann Institute of Science Rehovot, Israel
“Decoding viral infection with ribosome profiling”
19.05.2016
Prof. Ulf Dittmer Institute of Virology, Universitätsklinikum Essen, Essen, Germany
“The role of IFNa subtypes in anti-retroviral immunity”
30.05.2016
Dr. Luisa Stroeh Group Prof. Dr. Thilo Stehle, Interfaculty Institute of Biochemistry, University of Tübingen, Germany
“Structural Analysis and Glycan Receptor Specificities of Human Polyomaviruses”
02.06.2016
Prof. Jacques Fellay Global Health Institute École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland
“Human genomics of viral diseases”
07.07.2016
Assist. Prof. Marcel de Zoete Dept. Of Infectious Diseases and Immunology, Utrecht University, The Netherlands
“IgA leads the way – Identifying pathogenic commensals in inflammatory bowel disease”
16.08.2016
Dr. Paola Romagnoli Inserm U1043, Toulouse, France
“Life cycle of regulatory T lymphocytes”
18.08.2016
Prof. Florent Ginhoux A*Star Singapore, Singapore Immunology Network
“Dendritic cell and Macrophage Biology: from development to functions”
01.09.2016
Dr. Maria Teresa Catanese King’s College London, School of Medicine Department of Infectious Diseases London, UK
“Structure and composition of hepatitis C virus: Novel insights into virus-host interactions required for propagation of infection”
06.10.2016
Dr. Andreas Pichlmair Max Planck Institute of Biochemistry Martinsried, Germany
“Virus-Host interactions: From specific interactions to general mechanisms”
18.10.2016
Dr. Nicolas Suarez Centre for Virus Research (CVR), MRC-University of Glasgow, Glasgow, Scotland
“Sequencing Human Cytomegalovirus Genomes Directly from Clinical Material: Challenges and Opportunities”
19.10.2016
Dr. Sandrine Henri Lab. Bernard & Marie MALISSEN, Centre d’Immunologie de Marseille-Luminy (CIML), Marseille, France
“Complexity of the mononuclear phagocytic system of the skin: from phenotype to functions to vaccine”
03.11.2016
Prof. Félix A. Rey Head of Structure, Structural Virology, Department of Virology, Institut Pasteur, Paris, France
“Structural studies indicate a path for developing a single vaccine protecting simultaneously against dengue and Zika viruses”
01.12.2016
Dr. Michael Weekes Wellcome Trust Senior Clinical Fellow Honorary Consultant in Infectious Diseases, Addenbrooke’s Hospital Cambridge, Institute for Medical Research (CIMR), University of Cambridge, UK
“New insights into immune evasion by human herpesviruses from quantitative multiplexed proteomics”
05.03.2015
Prof. Dr. Ulrike Protzer Director of Institute of Virology, Technical University of Munich / Helmholtz Zentrum München – German Center for Environmental Health, Germany
“Immune Control of Hepatitis B Virus”
26.03.2015
Prof. Dr. Thomas Stamminger Group leader
“Human Cytomegalovirus Gene Regulation”, Institute of Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Germany
“Innate antiviral defense by PML nuclear bodies”
07.05.2015
Prof. Dr. Jürgen Ruland Head of the Institute of Clinical Chemistry and Pathobiochemistry, TUM School of Medicine, Munich, Germany
“Pattern Recognition Receptor signaling in anti-fungal Immunity”
04.06.2015
Prof. Juan Martin-Serrano Professor of Viral Cell Biology Department of Infectious Diseases, King’s College London School of Medicine, UK
“Controlling the ESCRT machinery in cell biology and viral pathogenesis”
02.07.2015
Prof. Dr. Anne Müller Institute of Molecular Cancer Research, University of Zurich, Switzerland
“Helicobacter pylori in health and disease”
09.07.2015
Prof. Adrian Whitehouse Professor of Molecular Virology, School of Molecular and Cellular Biology, University of Leeds, UK
“Targeting a novel mechanism of KSHV-induced genomic instability: a novel antiviral approach”
21.07.2015
Dr. Jorge Ruben Cabrera Centro de Biología Molecular Severo Ochoa, Madrid, Spain
“Secreted Herpes Simplex Virus-2 glycoprotein G, NGF, axonal growth and pain”
23.07.2015
Prof. Michael Roggendorf Institute of Virology, Technical University Munich, Germany
“Prime/Boost Therapeutic Vaccination against Chronic Hepatitis B: precinical Studies and Perspectives for the Treatment of Patients”
23.07.2015
Prof. Guntram Graßl Institute of Medical Microbiology and Hospital Hygiene, Hannover Medical School, Germany
“Proteases in chronic Salmonella infections”
03.09.2015
Prof. Wensheng Wei PI of BIOPIC, Center for Life Sciences and School of Life Sciences, Peking University, China
“Genome editing and human disease – have you CRISPRed?”
01.10.2015
Prof. Joseph Sun Assistant Professor of Immunology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, USA
“Immunological memory in natural killer cells”
16.10.2015
Prof. Karen Mossman Professor at the Department of Pathology and Molecular Medicine,McMaster Immunology Research Centre, McMaster University, West Hamilton, Canada
“Novel intrinsic/innate pathways that sense the “stress” of viral infections”
18.11.2015
Prof. Dr. Blossom Damania Boshamer Distinguished Professor of Microbiology & Immunology, University of North Carolina at Chapel Hill, USA
“KSHV encoded viral homologs: Roles in cell survival, migration, and immune evasion”
19.11.2015
Prof. Sebastian Springer Associate Professor of Biochemistry and Cell Biology, Department of Life Sciences and Chemistry, Jacobs University Bremen, Germany
“The murine cytomegalovirus immunoevasin gp40/m152 binds MHC class I molecules to retain them in the early secretory pathway”
20.11.2015
Dr. Ouyang Cyagen Biosciences Inc., Santa Clara, USA
“CRISPR/Cas9 and TurboKnockout: Technologies for Rapid Generation of Knockout/Knockin Mouse Models”
27.11.2015
Prof. John Sinclair Professor of Molecular Virology, University of Cambridge, Department of Medicine, Cambridge, UK
“Human cytomegalovirus latency results in profound cellular changes which can be targeted with novel therapeutics”
03.12.2015
Dr. Dirk Grimm Leader of CellNetworks Research Group “Virus-host interactions”, Heidelberg University Hospital, Germany
“Small viruses + tiny RNAs = a giant toolbox for gene & cell therapy”
09.01.2014
Prof. Christine Carrington-Kravatzky Department of Preclinical Sciences Faculty of Medical Sciences, The University of the West Indies, The Carribean
“Phylogeography and population dynamics of Dengue viruses in the Americas”
20.02.2014
Dr. Claudia Kemper MRC Centre for Transplantation, King´s College London, UK
“Unexpected novel roles for innate immunity in human Th1”
06.03.2014
Dr. Antonio Alcami Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Spain
“Poxvirus TNF and chemokine decoy receptors: what can we learn from them?”
24.04.2014
Prof. Peter Stäheli Institute for Virology, Department of Medical Microbiology and Hygiene, University Medical Center Freiburg, Germany
“Uncovering the role of Interferon-lambda in antiviral defense”
30.04.2014
Dr. Ariberto Fassati Head of Wohl Virion Centre, Division of Infection and Immunity, University College London, UK
“Heat shock protein 90 controls HIV-1 gene expression”
08.05.2014
Dr. Martin Rottenberg Department of Microbiology, Karolinska Institute Stockholm, Sweden
“Role of SOCS proteins in the outcome of Tuberculosis”
05.06.2014
PD Dr. Christian Sina Universitätsklinikum Schleswig-Holstein, Lübeck
“Circadian clock function maintains mucosal homeostasis in the gut”
26.06.2014
Dr. Thomas Gebhardt Department for Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Australia
“Antiviral T-cell immunity in skin”
04.09.2014
Dr. Olivier Neyrolles CNRS Research director Institute of Pharmacology and Structural Biology, Tuberculosis and Infection Biology department, CNRS Toulouse, France
“Inflammation and control of inflammation in tuberculosis”
04.12.2014
Dr. Julie Déchanet-Merville Composantes Innées de la Réponse Immunitaire et de la Différenciation, Université Bordeaux, France
“Control of CMV infection by gamma-delta T cells recognizing self stress antigens”
11.12.2014
Dr. Felix Meissner Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
“Proteomics of secreted proteins defines how proximal adaptors of TLRs regulate inflammation”
11.04.2013
Prof. Jürgen Haas Division of Pathway Medicine, University of Edinburgh, Scotland
“Genetic determinants of HSV-1 reactivation”
10.10.2013
Prof. Stephen Goff Howard Hughes Medical Institute, Columbia University Medical Center, New York, USA
“Players in the Silencing of Retroviral DNAs in Embryonic Stem Cells”
17.10.2013
Prof. Cecilia Söderberg-Nauclér Department of Medicine, Karolinska Institute, Stockholm, Schweden
“The role of CMV in tumors – New possibilities for treatment options?”
07.11.2013
Dr. Jason Mercer Institute of Biochemistry, ETH Zürich, Switzerland
“From Screen to Gene: Unraveling the Mystery of Poxvirus Genome Uncoating”
05.12.2013
Prof. Jonathan Ball School of Life Sciences and Nottingham Digestive Diseases, Centre Biomedical Research Unit, The University of Nottingham, UK
“Mimicking the neutralising face of the HCV E2 glycoprotein: The antibody-based vaccine challenge”
02.02.2012
Prof. Hartmut Hengel Institute of Virology, Heinrich Heine University, Düsseldorf
“Modulation of immune receptors by human cytomegalovirus”
04.04.2012
Prof. Thomas Borén Department Medical Biochemistry and Biophysics Umeå University, Umeå, Sweden
“Helicobacter pylori; multitalented adaptation of binding properties”
15.05.2012
Dr. Ramon Arens Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands
“Rational Design of Vaccines: Learning from Immune Evasion Mechanisms of Persistent Viruses”
14.06.2012
Prof. Greg Towers Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, UK
“Going under the radar with HIV: Host Virus Interactions and Innate Immunity”
12.07.2012
Prof. Paul Kellam The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
“Host and virus genetics of pandemic H1N1/09 influenza A virus”
10.09.2012
Prof. Karen Mossman Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
“Novel antiviral innate immune responses”
04.10.2012
Prof. Wolfram Brune Heinrich-Pette-Institute Leibniz Institute for Experimental Virology, Hamburg
“Modulation of the unfolded protein response by cytomegalovirus”
01.11.2012
Dr. Leif E. Sander Medical Department, Division of Infectiology and Pneumonology, Charité Berlin
“Innate Immune Sensing of Infectious Threats”
15.11.2012
Dr. Mario Schelhaas Emmy Noether Research Group: Virus Endocytosis, Westphalian Wilhelms-University of Münster
“The entry of oncogenic Human Papillomaviruses – a baroque dance with multiple host factors culminating in nuclear import during mitosis”
22.11.2012
Prof. Moriah Szpara Department of Molecular Biology, Princeton University, Pennsylvania State, USA
“Genetic Variation and Neurovirulence in Alpha-Herpesviruses” 06.12.2012 Dr. Hartmut Hengel Department of Virology, University Medical Center Freiburg “Cytomegalovirus immune escape and persistence”
07.02.2011
Dr. Eva Medina Head of the “Infection Immunology Research Group” Department of Medical Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig
“Small colony variants and the host immune response during persistent Staphylococcus aureus infection: Who’s governing, and who’s the governed?”
05.09.2011
Prof. Theo Geijtenbeek Dept. of Mol. Cell Biology & Immunology, VU Medical Centre, Amsterdam
“C-type lectins in infection and immunity”
01.12.2011
Prof. Michael S. Diamond Professor of Internal Medicine, Division of Infectious Diseases, Washington University in St. Louis, School of Medicine
“New Insights into Innate and Adaptive Immune Control of Flavivirus Infection”